A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression

Oncology Reports

Volumn 27, Issue 3, 2012, Pages 628-636

  Zhao, Xin ^a   Li, De Chun ^a   Zhao, Hua ^a   Li, Zhi ^a   Wang, Jian Xin ^b   Zhu, Dong Ming ^a   Zhou, Jin ^a   Cen, Jian Nong ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Angiogenesis; c Src; Pancreatic cancer; Proliferation; siRNA

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CD34 ANTIGEN; GEMCITABINE; GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; MESSENGER RNA; PLASMID VECTOR; PROTEIN KINASE P60; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CELL ASSAY; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; DENSITY; DNA TEMPLATE; DOWN REGULATION; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC ENHANCEMENT; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROVESSEL DENSITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE SRC; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REAL TIME QUANTITATIVE POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE SILENCING; GENE THERAPY; GENES, SRC; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PLASMIDS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863031064     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/oror.2011.1602     Document Type: Article

References (31)

1. Hidalgo M: Pancreatic cancer. N Engl J Med 362: 1605-1617, 2010.
2. Folkman J: Tumor angiogenesis: a possible control point in tumor growth. Ann Intern Med 82: 96-100, 1975.
3. Kerbel RS: Tumor angiogenesis. New Engl J Med 358: 2039-2049, 2008.
4. Dai J and Rabie A: VEGF: an essential mediator of both angiogenesis and endochondral ossification. J Dent Res 86: 937-950, 2007.
5. Midgley R, Kerr D: Bevacizumab - current status and future directions. Ann Oncol 16: 999-1004, 2005. (Pubitemid 41418303)
6. Ghaneh P, Costello E and Neoptolemos JP: Biology and management of pancreatic cancer. Postgrad Med J 84: 478-497, 2008.
7. Pan X, Sheng WH, Zhu QY, et al: Inhibition growth by adenovirus-mediated human Interleukin-24 expression in animal model. Cancer Biother Radio 23: 425-434, 2008.
8. Merritt WM, Bar-Eli M and Sood AK: The dicey role dicer: implications for RNAi therapy. Cancer Res 70: 2571-2574, 2010.
9. Agrawal N, Dasaradhi PVN, Mohmmed A, et al: RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev 67: 657-685, 2003. (Pubitemid 37549773)
10. Korc M: Pathways for aberrant angiogenesis in cancer. Mol Cancer 2: 1-8, 2003.
11. Shi X, Friess H, Kleeff J, et al: Pancreatic cancer: factors regulating tumor development, maintenance and metastasis. Pancreatology 1: 517-524, 2001. (Pubitemid 33681754)
12. Keleg S, Buchler P, Ludwig R, et al: Invasion and metastasis in pancreatic cancer. Mol Cancer 2: 14-20, 2003.
13. MacKenzie MJ: Molecular therapy in pancreatic adenocarcinonoma. Lancet Oncol 5: 541-549, 2004.
14. Takhar AS, Palaniappan P, Dhingsa R and Lobo DN: Recent developments in diagnosis of pancreatic cancer. BMJ 329: 668-673, 2004. (Pubitemid 39279289)
15. Jimeno A and Hidalgo M: Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol Cancer Ther 5: 787-796, 2006. (Pubitemid 43724577)
16. Frame CM: Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602: 114-130, 2002.
17. Thomas SM and Brugge JS: Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13: 513-607, 1997.
18. Summy JM and Gallick GE: Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22: 337-358, 2003. (Pubitemid 36791891)
19. Zhang Q, Thomas SM, Xi S, et al: Src family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. Cancer Res 64: 6166-6173, 2004. (Pubitemid 39129418)
20. Golas JM, Lucas J, Etienne C, et al: SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models. Cancer Res 65: 5358-5364, 2005. (Pubitemid 40827349)
21. Brunton VG, Avizienyte E, Fincham VJ, et al: Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection the role Src SH2 and catalytic functions and their consequences for tumor cell behaviour. Cancer Res 65: 1335-1345, 2005.
22. Lesslie DP, Summy JM, Parikh NU, et al: Vascular endothelial growth factor receptor-1 mediates migration human colorectal carcinoma cells by activation of Src family kinases. Br J Cancer 94: 1710-1717, 2006. (Pubitemid 43924937)
23. Schlessinger J: New roles for Src kinases in control of cell survival and angiogenesis. Cell 100: 293-296, 2000.
24. Boyer B, Bourgeois Y and Poupon MF: Src kinase contributes to metastatic spread of cells. Oncogene 21: 2347-2356, 2002. (Pubitemid 34407294)
25. Pories SE, Hess DT, Swenson K, et al: Overexpression of pp60csrc elicits invasive behavior in rat colon epithelial cells. Gastroenterology 114: 1287-1295, 1998. (Pubitemid 28243915)
26. Lutz MP, Esser IBS, Flossmannkast BBM, et al: Biochem Biophys Res Commun 243: 503-508, 1998.
27. Duxbury MS, Ito H, Zinner MJ, et al: siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity. J Am Coll Surg 198: 953-959, 2004. (Pubitemid 38759847)
28. Girling JE and Rogers PAW: Regulation endometrial vascular remodelling: role of the vascular endothelial growth factor family and the angiopoietin-TIE signaling system. Reproduction 138: 883-893, 2009.
29. Lewis CE, De Palma M and Naldini L: Tie2 expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res 67: 8429-8432, 2007. (Pubitemid 47437413)
30. Krause DS, Fackler MJ, Civin CI, et al: CD34: structure, biology, and clinical utility. Blood 87: 1-13, 1996. (Pubitemid 26018389)
31. Nielsen JS and McNagny KM: Novel functions of the CD34 family. J Cell Sci 121: 3683-3692, 2008.